Zobrazeno 1 - 10
of 339
pro vyhledávání: '"Hirokazu, Nagai"'
Autor:
Satoshi Yamasaki, Hiroatsu Iida, Akio Saito, Morio Matsumoto, Yoshiaki Kuroda, Tohru Izumi, Akiko M. Saito, Hiroaki Miyoshi, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Publikováno v:
Hematology Reports, Vol 16, Iss 2, Pp 336-346 (2024)
Romidepsin is an important therapeutic option for patients with peripheral T-cell lymphoma (PTCL). However, the timing of romidepsin administration remains controversial. The objective of this study was to characterize the safety and efficacy of romi
Externí odkaz:
https://doaj.org/article/5dc4c27699d24b06ab94ab4efa6a4af8
Autor:
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Dai Maruyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hisashi Kato, Toshiki Uchida, Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon Seok Eom, Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo, Dok Hyun Yoon, Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/be870e753e614a74b756e1f3d6e51924
Autor:
Tomonori Kawasaki, Tomoaki Tashima, Atsushi Enomoto, Jiro Ichikawa, Hirokazu Nagai, Chisako Muramatsu, Yasuhiro Nakamura, Kyoichi Kaira
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/e6135992573344499c3d4f480e9f56c4
Autor:
Lydia Scarfò, Manish R. Patel, Toby A. Eyre, Wojciech Jurczak, David Lewis, Thomas Gastinne, Shuo MA, Jonathon B. Cohen, Krish Patel, Jennifer R. Brown, Talha Munir, Ewa Lech-Maranda, Marc S. Hoffmann, Chaitra S. Ujjani, Bita Fakhri, Michael Wang, Koji Izutsu, Hirokazu Nagai, Constantine S. Tam, John F. Seymour, Joanna Rhodes, Julie Vose, Matthew Mckinney, James N. Gerson, Minal A. Barve, Bryone Kuss, Youngil Koh, Wei Gao, Amy S. Ruppert, Richard A. Walgren, Donald E. Tsai, Binoj Nair, Katherine Bao, Anthony R. Mato, Chan Y. Cheah, M Lia Palomba
Publikováno v:
HemaSphere, Vol 7, p e852670f (2023)
Externí odkaz:
https://doaj.org/article/a040220921ef4307b9e157dc91a3150b
Autor:
Isao Yoshida, Ken Ohmachi, Naomi Konishi, Ryunosuke Machida, Dai Maruyama, Wataru Munakata, Tsutomu Kobayashi, Tomohiro Kinoshita, Kiyoshi Ando, Hirokazu Nagai
Publikováno v:
HemaSphere, Vol 7, p e8882877 (2023)
Externí odkaz:
https://doaj.org/article/5a94517fe512462fada746f9fef7edac
Autor:
Tomonori Kawasaki, Tomoaki Tashima, Chisako Muramatsu, Akihiro Fujimoto, Yoko Usami, Hitomi Kodama, Jiro Ichikawa, Hirokazu Nagai, Kiyomi Taniyama
Publikováno v:
Cancer Reports, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Background Herein, for the first time, we present a case with mixed invasive micropapillary and neuroendocrine mammary neoplasm. Case The patient, a 65‐year‐old postmenopausal woman, had become aware of a tumor in her right breast 11 mon
Externí odkaz:
https://doaj.org/article/30e49cd2b72444b6ba3b08a3e4dbed1d
Autor:
Shinya Rai, Won Seog Kim, Kiyoshi Ando, Ilseung Choi, Koji Izutsu, Norifumi Tsukamoto, Masahiro Yokoyama, Kunihiro Tsukasaki, Junya Kuroda, Jun Ando, Michihiro Hidaka, Youngil Koh, Hirohiko Shibayama, Toshiki Uchida, Deok Hwan Yang, Kenji Ishitsuka, Kenichi Ishizawa, Jin Seok Kim, Hong Ghi Lee, Hironobu Minami, Hyeon Seok Eom, Mitsutoshi Kurosawa, Jae Hoon Lee, Jong Seok Lee, Won Sik Lee, Hirokazu Nagai, Takero Shindo, Dok Hyun Yoon, Shinichiro Yoshida, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
Publikováno v:
Haematologica, Vol 108, Iss 3 (2022)
Tucidinostat (formerly known as chidamide) is an orally available, novel benzamide class of histone deacetylase (HDAC) inhibitor that selectively blocks class I and class IIb HDAC. This multicenter phase IIb study aimed to investigate the efficacy an
Externí odkaz:
https://doaj.org/article/1f6b47ace5124b24847722a0557d0ba2
Autor:
Satoshi Yamasaki, Akiko Kada, Ilseung Choi, Hiroatsu Iida, Naohiro Sekiguchi, Naoko Harada, Morio Sawamura, Takeshi Shimomura, Takuya Komeno, Takahiro Yano, Isao Yoshida, Shinichiro Yoshida, Kazutaka Sunami, Terutoshi Hishita, Hiroshi Takatsuki, Koichi Ohshima, Morishige Takeshita, Akiko M. Saito, Hiromi Iwasaki, Hirokazu Nagai
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 507-516 (2020)
Abstract High‐dose chemotherapy and autologous stem cell transplantation (ASCT) are too toxic for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma (DLBCL). Therefore, effective and tolerable regimens for elderly patients
Externí odkaz:
https://doaj.org/article/d11d437a2b9d4f92acd077cf90fdfa3c
Autor:
Nobuhiko Imahashi, Mikiko Arakawa, Akari Iwakoshi, Mikiko Mori, Hirokazu Nagai, Hiroatsu Iida
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 569-570 (2022)
Externí odkaz:
https://doaj.org/article/3df7136432664559aee2ef839182ef75
Autor:
Naoyuki FUKUDA, Natsumi TAKAMARU, Kazuya AKITA, Hiroaki URATA, Hirokazu NAGAI, Youji MIYAMOTO
Publikováno v:
Japanese Journal of Oral and Maxillofacial Surgery. 69:58-62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08c79de4de05323d42135a4374e7b0c5
https://doi.org/10.5794/jjoms.69.58
https://doi.org/10.5794/jjoms.69.58